CLAR:NASDAQClarus Corporation Analysis

Clarus Corp. (CLAR) is trading at $2.92, comfortably above its 20‑day ($2.75) and 50‑day ($2.76) SMAs but still below the 200‑day SMA ($3.30), indicating a short‑term bounce within a longer‑term downtrend. The MACD histogram has turned positive and the RSI sits at a neutral 55.6, suggesting limited upside momentum while the price remains constrained between a support of $2.53 and resistance at $3.13. Recent earnings showed an 8.4% YoY revenue decline to $65.4 M, missing consensus, and the company posted a negative operating margin of –6.2% and a net loss per share of –$1.16, underscoring ongoing profitability challenges. Despite these headwinds, the firm announced a modest dividend of $0.025 per share, yielding 3.66%, with a low payout ratio of 14.7%, though sustainability is questionable given negative operating cash flow of –$6.8 M. Analysts have a consensus “buy” rating with a median price target of $3.48, yet the DCF‑derived fair value of $0.60 suggests the market may be pricing in optimistic turnaround expectations.
Strategically, Clarus is reviewing alternatives and expects 2026 sales of $245‑$255 M and adjusted EBITDA of $3‑$5 M, while gross margins have modestly improved by 240 bps. The stock’s high 30‑day volatility (≈62%) and elevated beta (≈1.4) amplify risk, but the current dividend yield and sub‑1× price‑to‑book ratio provide a value‑oriented appeal for investors willing to tolerate near‑term earnings volatility.